Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
LetterLetter

Effect of Traditional Cardiovascular Risk Factors on the Independent Relationship of Leptin with Atherosclerosis in Rheumatoid Arthritis

PATRICK H. DESSEIN, LINDA TSANG, ANGELA J. WOODIWISS and AHMED SOLOMON
The Journal of Rheumatology October 2014, 41 (10) 2087-2089; DOI: https://doi.org/10.3899/jrheum.140315
PATRICK H. DESSEIN
Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: dessein@telkomsa.net
LINDA TSANG
Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ANGELA J. WOODIWISS
Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
AHMED SOLOMON
Department of Rheumatology, Charlotte Maxeke Johannesburg Academic Hospital, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
  • eLetters
PreviousNext
Loading

To the Editor:

Leptin is an adipokine that regulates appetite and energy expenditure1. Both high and low leptin production can further increase cardiovascular (CV) risk1. Leptin is also produced in inflamed joints and implicated in the pathophysiology of rheumatoid arthritis (RA)2.

Whether leptin increases CV risk in RA is currently uncertain. Two studies reported a lack of association between leptin concentrations and carotid artery intima-media thickness (cIMT) in RA3,4. Leptin concentrations were also found to be unrelated to coronary artery classification scores in RA5. However, we recently reported an independent relationship between leptin concentrations and surrogate markers of early atherogenesis in young patients with RA2. Importantly, in the present context, carotid artery plaque is a more reliable indicator of atherosclerosis than cIMT6.

In our present study, we examined the independent relationships of leptin concentrations with cIMT and plaque in 217 (112 black and 105 white) patients with RA. Because the production and effects of adipokines on CV risk depend on pathophysiological context1,2,7, we also determined whether the presence of conventional and nonconventional CV risk factors modified leptin concentrations and their associations with atherosclerosis.

All patients were receiving disease-modifying agents for rheumatic disease that included tumor necrosis factor-α blockade and rituximab in 3.7% and 1.2% of them, respectively. The Human Research Ethics Committee (Medical) from The University of the Witwatersrand in Johannesburg, South Africa, approved the protocol (approval number: M06-07-33) and each participant gave informed written consent.

Carotid ultrasound measurement methods and its reproducibility in our setting were previously reported7. Carotid artery plaque was defined as a focal structure that encroaches into the arterial lumen of at least 0.5 mm or 50% of the surrounding intima-media thickness value, or demonstrates a thickness of > 1.5 mm as measured from the media-adventitia interface to the intima-lumen interface8.

Leptin concentrations were measured using solid-phase sandwich ELISA (QuantikineHS, R&D Systems Inc.). The lower detection limit was 7.8 pg/ml, and the interassay and intraassay coefficients of variation were 4.4% and 3.2%, respectively.

These characteristics were previously reported overall and in the different age quartiles in the present cohort2: demographic features, lifestyle factors, anthropometric measures, conventional metabolic risk factors, C-reactive protein concentrations, glomerular filtration rate (GFR), CV agents, and leptin concentrations. The median (interquartile range: IQR) erythrocyte sedimentation rate was 12 (5–28) mm/h.

The mean (SD) cIMT and plaque prevalence were 0.709 (0.109) mm and 40.6%, respectively. Leptin concentrations in all patients and relevant subgroups7 are given in Table 1. In univariate analysis, leptin concentrations were larger in black compared to white participants, and in patients with compared to those without major conventional CV risk factors and overall and abdominal obesity. Each of these differences was no longer significant in confounder and/or mediator-adjusted analysis2.

View this table:
  • View inline
  • View popup
Table 1.

Leptin concentrations (ng/ml) and the relationships with carotid artery plaque (per 1 SD increment) in all RA patients and subgroups. Univariate comparisons of leptin concentrations between subgroups were made using the Mann-Whitney U test and univariate associations of leptin concentrations with plaque in logistic regression models. Major risk factors comprised hypertension, dyslipidemia, smoking, and diabetes2.

Leptin concentrations were unrelated to cIMT in all patients and in those with and without conventional or nonconventional risk factors (data not shown). Table 1 also shows the relationships of leptin concentrations with carotid artery plaque. In univariate analysis, leptin concentrations were consistently unassociated with plaque. The number of major conventional CV risk factors affected the leptin concentrations-plaque prevalence association (interaction p = 0.02). In adjusted analysis, a 1-SD increment in leptin concentrations increased the OR for plaque 2.75-fold in patients with major conventional CV risk factors; the respective OR (95% CI) was 2.64 (1.18–5.92, p = 0.01) in patients with 2 (n = 40) or ≥ 3 (n = 10) major risk factors. Patients with major CV risk factors had a larger body mass index (BMI) and lower GFR than those without these risk factors [median (IQR) = 27.7 (24.0–32.8) vs 24.0 (21.7–28.5) kg/m2, p = 0.0001, and 94 (81–111) and 102 (89–123) ml/min, p = 0.05, respectively]. As shown in Table 2, the leptin concentrations-plaque prevalence relation was driven by the GFR and BMI. This suggests an effect of leptin on carotid plaque that is mediated by increasing adiposity and renal impairment. Alternatively, our results may conceptually represent a compensatory increase in leptin production that is targeted at reducing atherosclerosis5.

View this table:
  • View inline
  • View popup
Table 2.

Relations of leptin concentrations (1 SD increment) with carotid artery plaque among patients with major conventional cardiovascular risk factors. Associations were determined in logistic regression models.

Whereas in our previous study, leptin concentrations were associated with endothelial activation among patients aged < 50 years2, a relationship of leptin with plaque was not found in the respective group in our present investigation. This indicates that whereas leptin may be involved in early atherogenesis, this adipokine may not contribute to advanced atherosclerosis in young patients with RA. Interestingly, the leptin-endothelial activation relationship was also obesity-driven in RA2.

Several recorded characteristics were non-normally distributed in our present investigation. When we repeated the analyses using log-transformed variables in the mixed regression models, the results were materially unaltered (data not shown).

We found an effect of leptin on carotid artery plaque that is dependent on the number of major conventional risk factors, which were identified in 70% of participants. Indeed, Rho, et al also reported that the effect of leptin on coronary atherosclerosis may be mediated through interactions with other CV risk factors in RA5. Plaque represents advanced atherosclerosis6 that is strongly associated to coronary heart disease risk factors and incident coronary heart disease in both non-RA and RA subjects9,10. Leptin may contribute to the reported link between conventional risk factors and enhanced CV risk in RA. Consideration of leptin concentrations may improve CV risk stratification in patients with RA. These findings merit further investigation in future longitudinal studies.

Footnotes

  • Supported by the South African Medical Research Council (grant MRC2008_DES) and National Research Foundation.

REFERENCES

  1. 1.↵
    1. Koh KK,
    2. Park SM,
    3. Quon MJ
    . Leptin and cardiovascular disease: response to therapeutic intervention. Circulation 2008;117:3238–49.
    OpenUrlFREE Full Text
  2. 2.↵
    1. Dessein PH,
    2. Norton GR,
    3. Woodiwiss AJ,
    4. Tsang L,
    5. Solomon A
    . Age impacts on the independent relationships of leptin with cardiometabolic risk and surrogate markers of enhanced early atherogenesis in black and white patients with rheumatoid arthritis: a cross-sectional study. Rheumatol Int 2014;34:329–39.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Gonzalez-Gay MA,
    2. Gonzalez-Juanatey C,
    3. Rodriguez-Rodriguez L,
    4. Miranda-Filloy JA,
    5. Martin J,
    6. Llorca J
    . Lack of association between adipokines and ghrelin and carotid intima-media thickness in patients with severe rheumatoid arthritis. Clin Exp Rheumatol 2011;29:358–9.
    OpenUrlPubMed
  4. 4.↵
    1. Dessein PH,
    2. Norton GR,
    3. Badenhorst M,
    4. Woodiwiss AJ,
    5. Solomon A
    . Rheumatoid arthritis impacts on the independent relationships between circulating adiponectin concentrations and cardiovascular metabolic risk. Mediators Inflamm 2013;2013:461849.
    OpenUrlPubMed
  5. 5.↵
    1. Rho YH,
    2. Chung CP,
    3. Solus JF,
    4. Raggi P,
    5. Oeser A,
    6. Gedretsadik T,
    7. et al.
    Adipocytokines, insulin resistance, and coronary atherosclerosis in rheumatoid arthritis. Arthritis Rheum 2010;62:1259–64.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Solomon A,
    2. Norton GR,
    3. Woodiwiss AJ,
    4. Dessein PH
    . Obesity and carotid atherosclerosis in African black and Caucasian women with established rheumatoid arthritis: a cross-sectional study. Arthritis Res Ther 2012;14:R67.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Dessein PH,
    2. Tsang L,
    3. Norton GR,
    4. Woodiwiss AJ,
    5. Solomon A
    . Retinol binding protein 4 concentrations relate to enhanced atherosclerosis in obese patients with rheumatoid arthritis. PLoS One 2014;9:e92739.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Touboul PJ,
    2. Hennerici MG,
    3. Meairs S,
    4. Adams H,
    5. Amarenco P,
    6. Bornstein N,
    7. et al.
    Mannheim carotid intima-media thickness consensus (2004–2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. Cerebrovasc Dis 2007;23:75–80.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Dessein PH,
    2. Norton GR,
    3. Woodiwiss AJ,
    4. Joffe BI,
    5. Wolfe F
    . Influence of nonclassical cardiovascular risk factors on the accuracy of predicting subclinical atherosclerosis in rheumatoid arthritis. J Rheumatol 2007;34:943–51.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Evans MR,
    2. Escalante A,
    3. Battafarano DF,
    4. Freeman GL,
    5. O’Leary DH,
    6. del Rincon I
    . Carotid atherosclerosis predicts incident acute coronary syndrome in rheumatoid arthritis. Arthritis Rheum 2011;63:1211–20.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 41, Issue 10
1 Oct 2014
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Effect of Traditional Cardiovascular Risk Factors on the Independent Relationship of Leptin with Atherosclerosis in Rheumatoid Arthritis
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Effect of Traditional Cardiovascular Risk Factors on the Independent Relationship of Leptin with Atherosclerosis in Rheumatoid Arthritis
PATRICK H. DESSEIN, LINDA TSANG, ANGELA J. WOODIWISS, AHMED SOLOMON
The Journal of Rheumatology Oct 2014, 41 (10) 2087-2089; DOI: 10.3899/jrheum.140315

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Effect of Traditional Cardiovascular Risk Factors on the Independent Relationship of Leptin with Atherosclerosis in Rheumatoid Arthritis
PATRICK H. DESSEIN, LINDA TSANG, ANGELA J. WOODIWISS, AHMED SOLOMON
The Journal of Rheumatology Oct 2014, 41 (10) 2087-2089; DOI: 10.3899/jrheum.140315
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
  • eLetters

Related Articles

Cited By...

More in this TOC Section

  • Duration of Steroid Therapy and Temporal Artery Biopsy Positivity in Giant Cell Arteritis: A Retrospective Cohort Study
  • Desk Rejections: Not Without Due Deliberation
  • COVID-19 and IgA Vasculitis
Show more Letter

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire